Cryptococcus neoformans is the main etiological agent of cryptococcosis, a life-threatening systemic mycosis and one of the leading secondary infections among HIV-positive patients. In Colombia, cryptococcosis has an annual incidence of 2.4 cases per million inhabitants, affecting predominantly patients with AIDS. Despite the benefits of available antifungal drugs, the emergence of drug-resistant fungal strains and several side-effects resulting from long term medication limit their use. Therefore, adjunctive immunotherapy together with antifungal treatment is a promising option for the future. The aim of the present study is to use proteome analysis to characterize cryptococcal antigens in sera from patients with meningitis caused by C. neoformans obtained from the German central federal institution responsible for disease control and prevention (Robert-Koch-Institut, Berlin, Germany) and from the microbiology group of the National Institute of Health in Colombia. This will be the first study on the characterization of seroreactivity against cryptococcal allergens from Colombian patients. The project will be a unique multidisciplinary collaboration between researchers from Colombia and leading experts from Germany – with an outstanding track record – combining expertise in molecular biology, epidemiology of fungal infections, immunology and proteomics. The planned study will be the first approach to define allergens expressed by C. neoformans.
|Effective start/end date||5/1/18 → 12/31/19|
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Bogotá D.C.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.